Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial

被引：0
|
作者：
Lachmann, Helen [1 ,2 ]
Lauwerys, Bernard [3 ]
Miettunen, Paivi [4 ]
Kallinich, Tilmann [5 ]
Jansson, Annette [6 ]
Rosner, Itzhak
Manna, Raffaele [7 ]
Murias, Saramaria [8 ]
Savic, Sinisa [9 ]
Smeets, Serge [10 ]
De Benedetti, Fabrizio [11 ]
Simon, Anna [12 ]
机构：
[1] Royal Free Hosp, London, England
[2] UCL, London, England
[3] Catholic Univ Louvain, Brussels, Brussels Hoofds, Belgium
[4] Alberta Childrens Prov Gen Hosp, Calgary, ON, Canada
[5] Charite, Berlin, Germany
[6] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Munich, Germany
[7] Univ Cattolica Sacro Cuore, Rome, Lazio, Italy
[8] Univ Hosp La Paz, Madrid, Spain
[9] St James Univ Hosp, Leeds, W Yorkshire, England
[10] Novartis, Amsterdam, Netherlands
[11] Bambino Gesu Pediat Hosp, Rome, Italy
[12] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0802
引用
收藏
页数：3
相关论文
共 50 条
  • [1] CANAKINUMAB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RECURRENT FEVER SYNDROMES: RESULTS FROM A PHASE 3 TRIAL (CLUSTER)
    Lachmann, Helen J.
    Lauwerys, Bernard
    Miettunen, Paivi
    Kallinich, Tilmann
    Horneff, Gerd
    Brik, Riva
    Manna, Rafaelle
    Murias, Sara
    Savic, Sinisa
    Smeets, Serge
    De Benedetti, Fabrizio
    Simon, Anna
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 207 - 208
  • [2] Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
    Lachmann, H. J.
    Lauwerys, B.
    Miettunen, P.
    Kallinich, T.
    Jansson, A.
    Rosner, I.
    Manna, R.
    Murias, S.
    Savic, S.
    Smeets, S.
    De Benedetti, F.
    Simon, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : S51 - S58
  • [3] CANAKINUMAB IMPROVES PATIENT REPORTED OUTCOMES IN PATIENTS WITH PERIODIC FEVER SYNDROMES
    Lachmann, H.
    Simon, A.
    Anton, J.
    Gattorno, M.
    Kone-Paut, I.
    Ozen, S.
    Frenkel, J.
    Ben-Chetrit, E.
    Hoffman, H.
    Zeft, A.
    Joubert, Y.
    Lheritier, K.
    Speziale, A.
    Junge, G.
    Gregson, J.
    De Benedetti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 616 - 616
  • [4] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Strand, Vibeke
    Alemao, Evo
    Lehman, Thomas
    Johnsen, Alyssa
    Banerjee, Subhashis
    Ahmad, Harris A.
    Mease, Philip J.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [5] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A PHASE 3 TRIAL
    Navarro-Compan, V.
    Wei, J. C. C.
    Van den Bosch, F.
    Magrey, M.
    Wang, L.
    Fleishaker, D.
    Cappelleri, J. C.
    Wang, C.
    Wu, J.
    Dina, O.
    Fallon, L.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 704 - 704
  • [6] Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial
    Vibeke Strand
    Evo Alemao
    Thomas Lehman
    Alyssa Johnsen
    Subhashis Banerjee
    Harris A. Ahmad
    Philip J. Mease
    Arthritis Research & Therapy, 20
  • [7] NETAKIMAB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED DOUBLE-BLIND PHASE 3 TRIAL (PATERA)
    Korotaeva, T.
    Gaydukova, I.
    Mazurov, V.
    Samtsov, A.
    Khayrutdinov, V.
    Bakulev, A.
    Kokhan, M.
    Kundzer, A.
    Soroka, N.
    Dokukina, E.
    Eremeeva, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1691 - 1692
  • [8] Impact of Early Pain Improvement on Patient-reported Outcomes in Patients with Psoriatic Arthritis: Results from a Phase 3 Trial
    Bessette, Louis
    Joven-Ibanez, Beatriz
    Selmi, Carlo
    Chen, Naijun
    Kato, Koji
    Lippe, Ralph
    Zueger, Patrick
    Patel, Jayeshkumar
    Merola, Joseph
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 465 - 468
  • [9] Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial
    Bachert, Claus
    Hellings, Peter
    Mullol, Joaquim
    Hamilos, Daniel
    Naclerio, Robert
    Joish, Vijay N.
    Mannent, Leda
    Evans, Robert E.
    Grabher, Annette
    Abbe, Adeline
    Amand, Caroline
    Taniou, Christine
    Zhang, Donghui
    Fan, Chunpeng
    Pirozzi, Gianluca
    Graham, Neil
    Mastey, Vera
    Mahajan, Puneet
    Staudinger, Heribert
    Eckert, Laurent
    Khan, Asif
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [10] Pharmacokinetic and Pharmacodynamic Characteristics of Canakinumab in Patients with Periodic Fever Syndromes: Results from a Phase III Pivotal Umbrella Trial
    Frenkel, Joost
    Anton, Jordi
    Livneh, Avi
    Ben-Chetrit, Eldad
    Brogans, Paul
    Bujan-Rivas, Segundo
    Constantin, Minas
    De Benedetti, Fabrizio
    Gattorno, Marco
    Gul, Ahmet
    Hoffman, Hal M.
    Kone-Paut, Isabelle
    Lachmann, Helen
    Ozen, Seza
    Simon, Anna
    Van der Hilst, Jeroen
    Zeft, Andrew
    Speziale, Antonio
    Junge, Guido
    Xu, Lucy
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345